Activation of sonic hedgehog signaling pathway in S-type neuroblastoma cell lines

Abstract

The effects of Sonic hedgehog (Shh) signaling pathway activation on S-type neuroblastoma (NB) cell lines and its role in NB tumorigenesis were investigated. Immunohistochemistry was used to detect the expression of Shh pathway components—Patched1 (PTCH1) and Gli1 in 40 human primary NB samples. Western blotting and RT-PCR were used to examine the protein expression and mRNA levels of PTCH1 and Gli1 in three kinds of S-type NB cell lines (SK-N-AS, SK-N-SH and SHEP1), respectively. Exogenous Shh was administrated to activate Shh signaling pathway while cyclopamine was used as a selective antagonist of Shh pathway. S-type NB cell lines were treated with different concentrations of Shh or/and cyclopamine for different durations. Cell viability was measured by using MTT method. Apoptosis rate and cell cycle were assayed by flow cytometry. The xenograft experiments were used to evaluate the role of Shh pathway in tumor growth in immunodeficient mice. High-level expression of PTCH1 and Gli1 was detected in both NB samples and S-type NB cell lines. Cyclopamine decreased the survival rate of the three cell lines while Shh increased it, and the inhibition effects of cyclopamine could be partially reversed by shh pre-treatment. Cyclopamine induced the cell apoptosis and the cell cycle arrest in G₀/G₁ phase, while Shh induced the reverse effects and could partially prevent effects of cyclopamine. Cyclopamine could also inhibit the growth of NB in vivo. Our studies revealed that activation of the Shh pathway is important for survival and proliferation of S-type NB cells in vivo and in vitro through affecting cell apoptosis and cell cycle, suggesting a new therapeutic approach to NB.

Keywords

S-type neuroblastoma cell lines / Sonic hedgehog signaling pathway / cyclopamine

References

[1] MenegauxF., OlshanA.F., NegliaJ.P., et al.. Day care, childhood infections, and risk of neuroblastoma. Am J Epidemiol, 2004, 159(9): 843-851

[2] LisewskiD., RyanS., LimE.M., et al.. Concomitant composite adrenal pheochromocytoma, multiple gastric stromal tumors and pseudohermaphrodism in a patient with von Recklinghausen’s disease. Int Semin Surg Oncol, 2006, 3: 11

[3] DyerM.A.. Mouse models of childhood cancer of the nervous system. J Clin Pathol, 2004, 57(6): 561-576

[4] BrodeurG.M.. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer, 2003, 3(3): 203-216

[5] MarisJ.M., MatthayK.K.. Molecular biology of neuroblastoma. J Clin Oncol, 1999, 17(7): 2264-2279

[6] AhlgrenS.C., Bronner-FraserM.. Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death. Curr Biol, 1999, 9(22): 1304-1314

[7] FuM., LuiV.C., ShamM.H., et al.. Sonic hedgehog regulates the proliferation, differentiation, and migration of enteric neural crest cells in gut. J Cell Biol, 2004, 166(5): 673-684

[8] ThayerS.P., di MaglianoM.P., HeiserP.W., et al.. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature, 2003, 425(6960): 851-856

[9] KarhadkarS.S., BovaG.S., AbdallahN., et al.. Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature, 2004, 431(7009): 707-712

[10] Couvé-PrivatS., Le BretM., TraiffortE., et al.. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res, 2004, 64(10): 3559-3565

[11] Daya-GrosjeanL., Couvé-PrivatS.. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett, 2005, 225(2): 181-192

[12] HooperJ.E., ScottM.P.. Communicating with Hedgehogs. Nat Rev Mol Cell Biol, 2005, 6(4): 306-317

[13] RioboN.A., ManningD.R.. Pathways of signal transduction employed by vertebrate Hedgehogs. Biochem J, 2007, 403(3): 369-379

[14] RubinL.L., de SauvageF.J.. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov, 2006, 5(12): 1026-1033

[15] De PreterK., VandesompeleJ., HeimannP., et al.. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Bio, 2007, 8(1): 401

[16] MaoL., XiaY.P., ZhouY.N., et al.. A critical role of Sonic Hedgehog signaling in maintaining the tumorigenicity of neuroblastoma cells. Cancer Sci, 2009, 100(10): 1848-1855

[17] BarE.E., ChaudhryA., FarahM.H., et al.. Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol, 2007, 170(1): 347-355

[18] KenneyA.M., RowitchD.H.. Sonic hedgehog promotes G (1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol, 2000, 20(23): 9055-9067

[19] GartelA.L., SerfasM.S., TynerA.L.. p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med, 1996, 213(2): 138-149

[20] YoonJ.W., KitaY., FrankD.J., et al.. Gene expression profiling leads to identification of Gli1-binding elements in target genes and a role for multiple downstream pathways in Gli1-induced cell transformation. J Biol Chem, 2002, 277(7): 5548-5555

[21] XieJ., AszterbaumM., ZhangX., et al.. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci U S A, 2001, 98(16): 9255-9259

[22] TehM.T., WongS.T., NeillG.W., et al.. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res, 2002, 62(16): 4773-4780

[23] OhtaM., TateishiK., KanaiF., et al.. p53-independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res, 2005, 65(23): 10 822-10 829

[24] MaoL., XiaY.P., ZhouY.N., et al.. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma. Oncology, 2009, 77(3–4): 231-243

[25] MortonJ.P., MongeauM.E., KlimstraD.S., et al.. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA, 2007, 104(2): 5103-5108